Aladdin Healthcare Technologies SE Logo

Aladdin Healthcare Technologies SE

Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.

NMI | BE

Overview

Corporate Details

ISIN(s):
DE000A12ULL2
LEI:
391200M0N1PWTP19RE15
Country:
Germany
Address:
Unter den Linden 10, 10117 Berlin

Description

Aladdin Healthcare Technologies SE is a healthcare technology company that leverages artificial intelligence for drug discovery and diagnostics. The company's primary focus is on developing solutions for age-related conditions, with a significant emphasis on Alzheimer's disease. It utilizes a proprietary AI platform for virtual screening to identify novel small molecule drug compounds. In addition to drug development, the company develops AI-powered diagnostic tools and health screening services, which include applications for advanced image processing and analysis.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-09-02 16:41
Aladdin Healthcare Technologies SE: Antrag auf Eroffnung eines Insolvenzverfahr…
German HTML 4.8 KB
2022-08-15 13:30
Aladdin Healthcare Technologies SE: Notice of fine by BaFin in the total amoun…
English HTML 5.1 KB
2022-02-02 16:46 English HTML 15.1 KB
2022-02-02 15:25
DGAP-DD: Aladdin Healthcare Technologies SE english
English HTML 7.7 KB
2022-02-01 17:01 English HTML 14.2 KB
2022-02-01 15:54 English HTML 14.1 KB
2021-12-03 10:51 English HTML 14.2 KB
2021-11-24 09:00
Aladdin Healthcare Technologies SE approved for Listing on OTCQB in the USA
English HTML 8.7 KB
2021-11-03 09:00 English HTML 3.5 KB
2021-11-02 16:51 English HTML 15.2 KB
2021-11-02 16:47 English HTML 13.9 KB
2021-09-28 11:35 English HTML 3.9 KB
2021-09-23 18:41 English HTML 15.1 KB
2021-09-20 19:34
DGAP-DD: Aladdin Healthcare Technologies SE english
English HTML 7.6 KB
2021-07-14 08:36
Aladdin Healthcare Technologies with new research findings on COVID-19 diagnosis
English HTML 10.2 KB

Automate Your Workflow. Get a real-time feed of all Aladdin Healthcare Technologies SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aladdin Healthcare Technologies SE

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aladdin Healthcare Technologies SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-02-02 Menpes-Smith, Mr Wade Board Other None 211,425.00 EUR
2021-09-21 Continental Aktiengesellschaft Close relation Sell None 243,288.00 EUR
2021-09-20 Smith, Wade Board Other None 211,425.00 EUR

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.